Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice

British Journal of Pharmacology

Volumn 127, Issue 5, 1999, Pages 1165-1176

  Saadane, Nacéra ^a   Alpert, Lesley ^b   Chalifour, Lorraine E ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

c fos; c jun; Cardiac hypertrophy; Egr 1; GATA 4; Hydralazine; Isoproterenol; Nkx2.5; Phenylephrine; Regression

Indexed keywords

HYDRALAZINE; ISOPRENALINE; MYOSIN HEAVY CHAIN; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEART VENTRICLE HYPERTROPHY; IMMEDIATE EARLY GENE; MALE; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; DNA-BINDING PROTEINS; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; HOMEODOMAIN PROTEINS; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MYOSIN HEAVY CHAINS; PHENYLEPHRINE; RECEPTORS, ADRENERGIC; TRANSCRIPTION FACTORS; XENOPUS PROTEINS;

EID: 0032809986     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702676     Document Type: Article

References (68)

1. ARCECI, R.J., KING, A.A.J., SIMO, M.C., ORKIN, S.H. & WILSON, D.B. (1993). Mouse GATA-4: a retinoic acid-inducible GATA-hinding transcription factor expressed in endodermally derived tissues and heart. Mol. Cell. Biol., 13, 2235-2246.
2. 1,-adrenergic receptor signaling in cardiac cells. EMBO J., 12, 5131-5139.
3. ARGENTIN, S., ARDATI, A., TREMBLAY, S., LIHRMANN, I., ROBITAILLE, L., DROUIN, J. & NEMER, M. (1994). Development stage-specific regulation of atrial natriuretic factor gene transcription in cardiac cells. Mol. Cell. Biol., 14, 777-790.
4. BACHILLER, D. & RUTHER, U. (1990). Inducible expression of the proto-oncogene c-fos in transgenic mice. Archiv fur Geschwulstforschung, 60, 357-360.
5. BARKA, T., VAN DER NOEN, H. & SHAW, P.A. (1987). Protooncogene fos (c-fos) expression in the heart. Oncogen, 1, 439-443
6. BÖHN, M., CASTELLANO, M., AGABITI-ROSEI, E., FLESCH, M., PAUL, M. & ERDMANN, E. (1995). Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and β-adrenergic signal transduction. Circ., 92, 3006-3013.
7. BÖHM, M., MOLL, M., SCHMID, B., PAUL, M., GANTEN, D., CASTELLANO, M, & ERDMANN, E. (1994). β-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hrpertensoin, 24, 653-662.
8. BOLUYT, M.O., LONG, X., ESCHENHAGEN, T., MENDE, U., SCHMITZ, W., CROW, M.T. & LAKATTA, E.G. (1995). Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am. J. Phyxiol., 269, H638-H647.
9. BRAND, T., SHARMA, H.S. & SCHAPER, W. (1993). Expression of nuclear proto-oncogenes in isoproterenol-induced cardiac hypertrophy. J. Mol. Cell. Cardiol., 25, 1325-1337.
10. 1- and β-adrenergic receptors. J. Mol. Cell. Cardiol., 25, 1037-1046.
11. CASSIDY, S.C., McGOVERN, J.J., CHAN, D.P. & ALLEN, H.D. (1997). Effects of commonly used adrenergic agonists on left ventricular function and systemic vascular resistance in young piglets. Am. Heart J., 133, 174-183.
12. CHEN, C.Y., CROISSANT, J., MAJESKY, M., TOPOUZ, S., MCQUINN, T., FRANKOVSKY, M.J. & SCHWARTZ. R.J. (1996). Activation of the cardiac alpha-actin promoter depends upon serum response factor, Tinman homologue, Nkx2-5, and intact serum response elements. Dev. Genet., 19, 119-130.
13. CHIRGWIN, J.M., PRZYBULA, A.E., MACDONALD, R.J. & RUTTER, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochem., 18, 5294-5299.
14. DUROCHER, D., CHARRON, F., WARREN, R., SCHWARTZ, R.J. & NEMER, M. (1997). The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J., 16, 5687-5696.
15. DUROCHER, D., CHEN, C.-Y., ARDATI, A., SCHWARTZ, R.J. & NEMER, M. (1996). The atrial natriurelic factor promoter is a downstream target for Nkx-2.5 in the myocardium. Mol. Cell. Biol., 16, 4648-4655.
16. GANDARILLAS, A. & WATT, F.M. (1995). Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinoeytes. Oncogene, 11, 1403-1407.
17. GASHLER, A. & SUKHATME, V.P. (1995). Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucl. Acids Res., 50, 191-224.
18. GOLOMB, E., ABASSI, Z.A., CUDA, G., STYLIANOU, M., PANCHEI., V.R., TRACHEWSKY, D. & KEISER, H.R. (1994). Angiotensin II maintains, hut does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am. J. Physiol., 267, H1496-1506.
19. GRÉPIN, C., DAGNINO. L., ROBITAILLE, L, HABERSTROH, L., ANTAKLY, T. & NEMER, M. (1994). A hormone-encoding gene identifies a pathway for cardiac hut not skeletal muscle gene transcription. Mol. Cell. Biol., 14, 3115-3129.
20. GUPTA, M.P., GUPTA, M., ZAK, R. & SUKHATME, V.P. (1991). Egr-1, a serum-inducible zinc finger protein, regulates transcription of the rat cardiac α-myosin heavy chain gene. J. Biol. Chem., 266, 12813-12816.
21. GUYTON, A.C. (1992). Kidneys and fluids in pressure regulation; small volume but large pressure changes. Hyperten., 19, 12-18.
22. HANNAN, R.D. & WEST, A.K. (1991). Adrenergic agents, but not triiodo-1-thyronine induce c-fos and c-myc expression in the heart. Basic Res. Cardiol., 86, 154-164.
23. 1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc. Natl. Acad. Sci. U.S.A., 94, 7543-7548.
24. HOLDER, E.L., AL MOUSTAFA, A.-E. & CHALIFOUR, L.E. (1995). Molecular remodeling in hypertrophied hearts from polyoma-virus large T-antigen transgenic mice. Mol. Cell. Biochem., 152, 131-141.
25. HUANG, R.P., FAN, Y., NI, Z., MERCOLA, D. & ADAMSON, E.D. (1997). Reciprocal modulation between Sp1 and Egr-1. J. Cell. Biochem., 66, 489-499.
26. IP, H.S., WILSON, D.B., HEIKINHEIMO, M., TANG, Z., TING, C.N., SIMON, M.C., LEIDEN, J.M. & PARMACEK, M.S. (1994), The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells. Mol. Cell. Biol., 14, 7517-7526.
27. IWAKI, K., SUKHATME, V.P., SHUBEITA, H.E. & CHIEN, K.R. (1990). Alpha- and beta-adrenergic stimulation induced distinct patterns of immediate early gene expression in neonatal rat myocardial cells. Fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response. J. Biol. Chem., 265, 13809-13817.
28. JOHN, S.W.M., KREGE. J.H., OLIVER, P.M., HAGAMAN, J.R., HODGIN, J.B., PANG, S.C., FLYNN, T.G. & SMITHIES, O. (1995). Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science, 267, 679-681.
29. JOHNSON, R.S., LINGEN, B.V., PAPAIOANNOU, V. & SPIEGELMAN, B.M. (1993). A null mutation at the c-Jun locus causes embryonic lethality and retarded cell growth in culture. Genen Dev., 7, 1309-1317.
30. KHACHIGIAN, L.M. & COLLINS, T. (1997). Inducible expression of Egr-1 dependent genes. A paradigm of transcriptional activation in vascular endoethelium. Circ. Res., 81, 457-461.
31. KITSIS, R.N. & LEINWAND, L.A. (1992). Discordance between gene regulation in vitro and in vivo. Gene Expression, 2, 313-317.
32. KOBILKA. B. (1993). Adrenergic and muscarinic receptors of the heart. In Molecular Basis of Cardiology, ed. Roberts, R, pp. 211-238. London: Black well Scientific Publications.
33. KOVACIC-MILIVOJEVIC, B., WONG, V.S.H. & GARDNER, D.G. (1996). Selective regulation of the atrial natriuretic peptide gene by individual components of the activator protein-1 complex. Endocrinology, 137, 1108-1117.
34. KUO, C.T., MORRISEY, E.E., ANANDAPPA, R., SIGRISI, K., LU, M.M., PARMACEK, M.S., SOUDAIS, C. & LEIDEN, J.M. (1997). GATA-4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev., 11, 1048-1060.
35. KURABAYASHI, M., KOMURO, I., SHIBASAKI, Y., TSUCHIMOCHI, H., TAKAKU, F. & YAZAKI, Y. (1990). Functional identification of the transcriptional regulatory elements within the promoter region of the human ventricular myosin alkali light chain gene. J. Biol. Chem., 265, 19271-19278.
36. LAYCOCK, S.K., KANE, K.A., MCMURRAY, J. & PARRATT, J.R. (1996). Captopril and norepinephrine-induced hypertrophy and haemaodynamics in rats. J. Cardiovasc. Pharmacol., 27, 667-672.
37. LAYCOCK, S.K., MCMURRAY, J., KANE, K.L. & PARRAT, J.R. (1995). Effects of chronic norepinephrine administration on cardiac-function in rats. J. Cardiovasc. Pharmacol., 26, 584-589.
38. LEE, R.T., BLOCH, K.D., PFEFFER, J.M., PFEFFER, M.A., NEER, E.J. & SEIDMAN, C.E. (1988). Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J. Clin. Invest., 81, 431-434.
39. LEE, S.L., TOURTELLOTTE, L.C., WESSELSCHMIDT, R.L. & MIL-BRANDT, J. (1995). Growth and differentiation proceeds normally in cells deficient in the immediate early gene NGFI-A. J. Biol. Chem., 270, 9971-9977.
40. LIEBERMANN, D.A. & HOFFMAN, B. (1998). MyD genes in negative growth control. Oncogene, 17, 3319-3329.
41. LIU, C., RANGNEKAR, V.M., ADAMSON, E. & MERCOLA, D. (1998). Suppression of growth and transformation and induction of apoptosis by Egr-1. Cancer Gene Therapy, 5, 3-18.
42. LORD, K.A., ABDOLLAHI, A., HOFFMANN-LIEBERMANN, B. & LIEBERMANN, D.A. (1993). Proto-oncogenes of the fos/jun family of transcripton factors are positive regulators of myeloid differentiation. Mol. Cell. Biol., 13, 841-851.
43. LYONS, I., PARSONS, L.M., HARTLEY, L., LI, R., ANDREWS, J.E., ROBB, L. & HARVEY, R.P. (1995). Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx-2.5. Genes Dev., 9, 1654-1666.
44. MILANO, C.A., ALLEN, L.F., ROCKMAN, H.A., DOLBER, P.C., MCMINN, T.R., CHIEN, K.R., JOHNSON, T.D., BOND, R.A. & LEFKOWITZ, R.J. (1994). Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor. Science. 264, 582-586.
45. MILS, V., PIETTE, J., BARETTE, C., VEYRUNE, J-L, TESNIERE, A., ESCOT, C., GUILHOU, J-J. & BASSET-SEQUIN, N. (1997). The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene, 14, 1555-1561.
46. MITCHELL, G.F, PFEFFER, M.A., FINN, P.V. & PFEFFER, J.M. (1996). Equipotent antihypertensive agents variously effect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. Circ., 94, 2923-2929.
47. MOLKENTIN, J.D., KALVAKOLANU, D.V. & MARKHAM, B.E. (1994). Transcription factor GATA-4 regulates cardiac muscle-specific expression of the α-myosin heavy chain gene. Mol. Cell. Biol., 14, 4947-4957.
48. MOLKENTIN, J.D., LIN, Q., DUNCAN, S.A. & OLSON, E.N. (1997). Requirement of the transcription factor GATA-4 for heart tube formation and morphogenesis. Genes Dev., 11, 1061-1072.
49. MOLKENTIN. J.D., LU, J.-R., ANTOS, C.L., MARKHAM, B., RICHARDSON, J., ROBBINS, J., GRANT, S.R. & OLSON, E.N. (1998). A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell, 93, 215-228.
50. OSAKI, J., HANEDA, T., SAKAI, H. & KIKUCHI, K. (1997). cAMP-mediated c-fos expression in pressure-overloaded acceleration of protein synthesis in adult rat heart. Cardio. Res., 33, 631-640.
51. ÖSTMAN-SMITH, I. (1981). Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy. Clin. Science, 61, 265-272.
52. PANTERNE, B., HATZFELD, J., BLANCHARD, J.-M., LEVESQUE, J.-P., BERTHIER, R., GINSBURG, M. & HATZFELD, A. (1992). c-Fos mRNA constitutive expression by mature human megakaryocytes. Oncogene, 7, 2341-2344.
53. POLLAK, P.S. (1995). Proto-oncogenes and the cardiovascular system. Chest, 107, 826-835.
54. RAUSCHER III, F.J., VOULALAS, P.J., FRANZA JR, B.R. & CURRAN, T. (1988). Fos and Jun hind cooperatively to the AP-1 site: reconstitution in vitra. Genes Dev., 2, 1687-1699.
55. REDDY, D.S., SINGH, M. & GANGULY, N.K. (1996). Effects of long-term hydralazine treatment on myocardial structure and expression of myosin isogenes in cardiac pressure overload in rats. Exp. Clin. Pharmacol., 18, 261-271.
56. ROCKMAN, H.A., KOCH, W.J. & LEFKOWITZ, R.J. (1997). Cardiac function in genetically engineered mice with altered adrenergic receptor signalling. Am. J. Physiol., 272, H1553-H1559.
57. ROSENWEIG, A., HALAZONETIS, T.D., SEIDMAN, J.G. & SEIDMAN, C.E. (1991). Proximal regulatory domains of rat atrial natriuretic factor gene. Circ., 84, 1256-1265.
58. RUTHER, U., KOMITOWSKI, D., SCHUBERT, F.R. & WAGNER, E.F. (1989). C-fos expression induces bone tumors in transgenic mice. Oncogene 4, 861-865.
59. SAADANE, N., ALPERT, L. & CHALIFOUR, L.E. (1999). TAFII250, Egr-1, and D-type cyclin expression in mice and neonatal rat cardiomyocytes treated with doxorubicin. Am. J. Physiol., 276, H803-H814.
60. SAEZ, E., RUTBERG, S.E., MUELLER, E., OPPENHEIM, H., SMOLUK, J., YUSPA, S.H. & SPIEGELMAN, B.M. (1995). c-Fos is required for malignant progression on skin tumors. Cell, 82, 721-732.
61. SCHNEIDER, M.D. & PARKER, T.G. (1993). Molecular mechanisms of cardiac growth and hypertrophy: Myocardial growth factors and proto-oncogenes in development and disease. In Molecular Basis of Cardiology. Roberts, R. pp. 113-134. London: Blackwell Scientific Publications.
62. SEPULVEDA, J.L., BELAGULI, N., NIGAM, V., CHEN, C.-Y., NEMER, M. & SCHWARTZ, R.J. (1998). GATA-4 and Nkx2.5 coactive Nkx-2 DNA binding targets: role for regulating early cardiac gene expression. Mol. Cell. Biol., 18, 3405-3415.
63. SMEYNE, R.J., VENDRELL, M., HAYWARD, M., BAKER, S.J., MIAO, G.G., SCHILLING, K., ROBERTSON, L.M., CURRAN, T. & MORGAN, J.L. (1993). Continuous c-fos expression precedes programmed cell death in vivo. Nature, 363, 166-169.
64. SOONPAA, M.H. & FIELD, L.J. (1994). Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am. J. Physiol., 266, H1439-H1445.
65. SUSIC, D., NUNEZ, E., FROHLICH, E.D. & PRAKASH, O. (1996). Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension, 28, 265-268.
66. VAN BILSEN, M. & CHEIN, K.R. (1993). Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc. Res., 27, 1140-1149.
67. WANG, Z.-Q., OVITT, C., GRIGORIADIS, A.E., MOHLE-STEINLEIN, U., RÜTHER, U. & WAGNER, E.F., (1992). Bone and hematopoietic defects in mice lacking c-fos. Nature, 360, 741-745.
68. ZIERHUT, W. & ZIMMER, H.-G. (1989). Significance of myocardial α-and β-adrenoreceptors in catecholamine-induced cardiac hypertrophy. Cir. Res., 65, 1417-1425.